Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction

Arthritis Research and Therapy

Volumn 14, Issue 1, 2012, Pages

  Krishnan, Eswar ^a   Pandya, Bhavik J ^b   Lingala, Bharathi ^a   Hariri, Ali ^c   Dabbous, Omar ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Takeda Pharmaceuticals International Inc   (United States)

^c TAKEDA PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; COLCHICINE; PLACEBO; PROBENECID; NONSTEROID ANTIINFLAMMATORY AGENT; URIC ACID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GOUT; HUMAN; HYPERURICEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK; BLOOD; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLASSIFICATION; CORONARY ARTERY DISEASE; HEART INFARCTION; MIDDLE AGED; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; RISK FACTOR; STATISTICS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; GOUT; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RISK FACTORS; STROKE; URIC ACID;

EID: 84855759189     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3684     Document Type: Article

References (35)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, et al. Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 2010, 121:948-954.
2. Cannon CP, Greenberg BH. Risk stratification and prognostic factors in the post-myocardial infarction patient. Am J Cardiol 2008, 102:13G-20G. 10.1016/j.amjcard.2008.06.006, 18722187.
3. Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, Robertson DH, Hille DA, DeLucca PT, DiBattiste PM, Demopoulos LA, Weintraub WS, Braunwald E. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA 2001, 286:2405-2412. 10.1001/jama.286.19.2405, 11712935.
4. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem 2007, 53:2112-2118. 10.1373/clinchem.2007.090613, 17932131.
5. Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe AS. Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. Clin Biochem 2007, 40:326-329. 10.1016/j.clinbiochem.2006.10.025, 17292342.
6. Krishnan E, Pandya BJ, Chung L, Dabbous O. Hyperuricemia and the risk for subclinical coronary atherosclerosis-data from a prospective observational cohort study. Arthritis Res Ther 2011, 13:R66. 10.1186/ar3322, 3132061, 21501486.
7. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med 2005, 118:816-826. 10.1016/j.amjmed.2005.03.043, 16084170.
8. Krishnan E. Gout and coronary artery disease: epidemiologic clues. Curr Rheumatol Rep 2008, 10:249-255. 10.1007/s11926-008-0039-0, 18638434.
9. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980, 243:661-669.
10. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004, 350:1093-1103. 10.1056/NEJMoa035700, 15014182.
11. Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, Hochberg MC. Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med 1997, 157:1436-1440. 10.1001/archinte.1997.00440340060005, 9224221.
12. McAdams MA, Maynard JW, Baer AN, Kottgen A, Clipp S, Coresh J, Gelber AC. Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J Rheumatol 2011, 38:135-141. 10.3899/jrheum.100418, 21123328.
13. Dalbeth N, Kumar S, Stamp L, Gow P. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. J Rheumatol 2006, 33:1646-1650.
14. Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 2006, 81:925-934. 10.4065/81.7.925, 16835972.
15. Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology 2009, 114:300-305. 10.1159/000239860, 19776568.
16. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008, 58:623-630. 10.1002/art.23121, 18240236.
17. Thanassoulis G, Brophy JM, Richard H, Pilote L. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 2010, 170:1358-1364. 10.1001/archinternmed.2010.198, 20696962.
18. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 2009, 61:885-892. 10.1002/art.24612, 2714267, 19565556.
19. Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009, 61:225-232. 10.1002/art.24164, 19177541.
20. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group. Circulation 1980, 62:V79-84.
21. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000, 43:103-108. 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C, 10643705.
22. Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther 2003, 17:397-414.
23. Krishnan E. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 2010, 49:1229-1238.
24. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293. 10.1161/01.HYP.0000072820.07472.3B, 12743010.
25. Gersch C, Palii SP, Imaram W, Kim KM, Karumanchi SA, Angerhofer A, Johnson RJ, Henderson GN. Reactions of peroxynitrite with uric acid: formation of reactive intermediates, alkylated products and triuret, and in vivo production of triuret under conditions of oxidative stress. Nucleosides Nucleotides Nucleic Acids 2009, 28:118-149. 10.1080/15257770902736400, 2742358, 19219741.
26. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008, 26:269-275. 10.1097/HJH.0b013e3282f240bf, 18192841.
27. Price KL, Sautin YY, Long DA, Zhang L, Miyazaki H, Mu W, Endou H, Johnson RJ. Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol 2006, 17:1791-1795. 10.1681/ASN.2006030264, 16775029.
28. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001, 38:1101-1106. 10.1161/hy1101.092839, 11711505.
29. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006, 114:2508-2516. 10.1161/CIRCULATIONAHA.106.651117, 17130343.
30. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004, 94:932-935. 10.1016/j.amjcard.2004.06.032, 15464681.
31. Engberding N, Spiekermann S, Schaefer A, Heineke A, Wiencke A, Muller M, Fuchs M, Hilfiker-Kleiner D, Hornig B, Drexler H, Landmesser U. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?. Circulation 2004, 110:2175-2179. 10.1161/01.CIR.0000144303.24894.1C, 15466649.
32. Guan W, Osanai T, Kamada T, Hanada H, Ishizaka H, Onodera H, Iwasa A, Fujita N, Kudo S, Ohkubo T, Okumura K. Effect of allopurinol pretreatment on free radical generation after primary coronary angioplasty for acute myocardial infarction. J Cardiovasc Pharmacol 2003, 41:699-705. 10.1097/00005344-200305000-00005, 12717099.
33. Rentoukas E, Tsarouhas K, Tsitsimpikou C, Lazaros G, Deftereos S, Vavetsi S. The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol 2010, 145:257-258. 10.1016/j.ijcard.2009.08.037, 19775763.
34. Tarkka MR, Vuolle M, Kaukinen S, Holm P, Eloranta J, Kaukinen U, Sisto T, Kataja J. Effect of allopurinol on myocardial oxygen free radical production in coronary bypass surgery. Scand Cardiovasc J 2000, 34:593-596. 10.1080/140174300750064549, 11214014.
35. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008, 300:924-932. 10.1001/jama.300.8.924, 2684336, 18728266.